Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age

被引:0
作者
Vijay Yajnik
Nabeel Khan
Marla Dubinsky
Jeffrey Axler
Alexandra James
Brihad Abhyankar
Karen Lasch
机构
[1] Harvard Medical School,Massachusetts General Hospital
[2] University of Pennsylvania,Perelman School of Medicine
[3] Mount Sinai Hospital,Toronto Digestive Disease Associates
[4] University of Toronto,undefined
[5] Takeda Development Centre Europe Ltd,undefined
[6] Takeda Pharmaceuticals U.S.A. Inc,undefined
来源
Advances in Therapy | 2017年 / 34卷
关键词
Crohn’s disease; Ulcerative colitis; Vedolizumab;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:542 / 559
页数:17
相关论文
共 100 条
  • [1] Baumgart DC(2012)Crohn’s disease Lancet 380 1590-1605
  • [2] Sandborn WJ(2012)Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 46-54
  • [3] Molodecky NA(2011)Inflammatory bowel disease of the elderly: frequently asked questions (FAQs) Am J Gastroenterol 106 1889-1897
  • [4] Soon IS(2014)IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol 11 88-98
  • [5] Rabi DM(2014)Clinical implications of ageing for the management of IBD Nat Rev Gastroenterol Hepatol 11 128-138
  • [6] Katz S(2014)Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases Am J Gastroenterol 109 1795-1802
  • [7] Pardi DS(2014)Systematic review with meta-analysis: inflammatory bowel disease in the elderly Aliment Pharmacol Ther 39 459-477
  • [8] Ruel J(2011)Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease Clin Gastroenterol Hepatol 9 30-35
  • [9] Ruane D(2015)Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease Aliment Pharmacol Ther 42 441-451
  • [10] Mehandru S(2013)Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease Inflamm Bowel Dis 19 309-315